DavidRBerkMD

PubMed

• 4 citations
  The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score
  Kim A. Papp, Mark Lebwohl, Leon H Kircik, David M. Pariser, Bruce Strober, Gerald G. Krueger, David R. Berk, Lynn Navale, Robert C. Higham> ;Dermatology and Therapy. 2021 Jul 8
• 5 citations
  Biallelic variants in RNU12 cause CDAGS syndrome
  Chao Xing, Mohammed Kanchwala, Jonathan J. Rios, Tommy Hyatt, Richard C. Wang, An Tran, Irene Dougherty, Andrea Tovar-Garza, Christy Purnadi, Monique G. Kumar, David R...> ;Human Mutation. 2021 Jun 3
• 10 citations
  Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
  Kim A. Papp, Melinda Gooderham, Michael Droege, Charlotte Merritt, David W Osborne, David R. Berk, Archie W. Thurston Jr., Valerie H. Smith, Howard Welgus> ;Journal of Drugs in Dermatology. 2020 Aug 1
• 46 citations
  Trial of Roflumilast Cream for Chronic Plaque Psoriasis
  Mark Lebwohl, Kim A. Papp, Linda Stein Gold, Melinda Gooderham, Leon H Kircik, Zoe Diana Draelos, Steven Kempers, Mathew Zirwas, Kathleen Smith, David Osborne, Marie-L...> ;The New England Journal of Medicine. 2020 Jul 15
• 14 citations
  Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.
  David M. Pariser, Lawrence Green, Edward Lain, Carsten Schmitz, Amy S Chinigo, Brian McNamee, David R. Berk> ;The Journal of Clinical and Aesthetic Dermatology. 2019 Nov 1
• 6 citations
  Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials
  Linda Stein-Gold, Leon H Kircik, Zoe Diana Draelos, Philip Werschler, Janet DuBois, Edward Lain, Leslie Baumann, David J. Goldberg, Joely Kaufman, Emil Tanghetti, Gurp...> ;Journal of Drugs in Dermatology. 2018 Nov 1
• 30 citations
  Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial
  Zoe Diana Draelos, Michael H. Gold, Robert Weiss, Leslie Baumann, Steven Grekin, Deanne Mraz Robinson, Steven Kempers, Nancy Alvandi, Emily Weng, David R. Berk, Gurpre...> ;Journal of the American Academy of Dermatology. 2018 Jun 1
• 10 citations
  Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0
  Emil Tanghetti, Jeffrey S. Dover, David J. Goldberg, Sunil Dhawan, Lei Luo, David R. Berk, Gurpreet Ahluwalia, Nancy Alvandi> ;Journal of Drugs in Dermatology. 2018 Jun 1
• 6 citations
  Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment.
  Michael H. Gold, Mark Lebwohl, Brian S. Biesman, Deanne Mraz Robinson, Lei Luo, David R. Berk, Gurpreet Ahluwalia, Nancy Alvandi> ;Journal of the American Academy of Dermatology. 2018 May 31
• 12 citations
  Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.
  Janet DuBois, Jeffrey S. Dover, Terry M. Jones, Robert Weiss, David R. Berk, Gurpreet Ahluwalia> ;Journal of Drugs in Dermatology. 2018 Mar 1
• 3 citations
  WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29...
  Linda Stein-Gold, Leon H Kircik, Zoe Diane Draelos, Philip Werschler, Janet DuBois, Edward Lain, Leslie Baumann, David J. Goldberg, Joely Kaufman, Emil Tanghetti, Nanc...> ;Journal of the American Academy of Dermatology. 2018 Feb 4
• 4 citations
  Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
  Zoe Diana Draelos, David Rodriguez, Steven Kempers, Suzanne Bruce, Marina I Peredo, Jeanine Downie, Joan-En Chang-Lin, David R. Berk, Shiling Ruan, Alexandre Kaoukhov> ;Journal of Drugs in Dermatology. 2017 Jun 1
• 6 citations
  Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.
  Michael Jarratt, Terry M. Jones, Joan-En Chang-Lin, Warren Tong, David R. Berk, Vince Lin, Alexandre Kaoukhov> ;Journal of Drugs in Dermatology. 2016 Oct 1
• 22 citations
  Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter,...
  Lawrence F. Eichenfield, Ted Lain, Ellen H. Frankel, Terry M. Jones, Joan-En Chang-Lin, David R. Berk, Shiling Ruan, Alexandre Kaoukhov> ;Journal of Drugs in Dermatology. 2016 May 1
• 23 citations
  Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter,...
  Lawrence F. Eichenfield, Ted Lain, Ellen H. Frankel, Terry M. Jones, Joan-En Chang-Lin, David R. Berk, Shiling Ruan, Alexandre Kaoukhov> ;Journal of Drugs in Dermatology. 2016 May 1
• 11 citations
  Skin Findings in Williams Syndrome
  Beth A. Kozel, Susan J. Bayliss, David R. Berk, Jessica L. Waxler, Russell H. Knutsen, Joshua R. Danback, Barbara R. Pober> ;American Journal of Medical Genetics. Part A. 2014 Sep 1
• 15 citations
  Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
  Monique G. Kumar, Rebecca S. Foreman, David R. Berk, Susan J. Bayliss> ;Pediatric Dermatology. 2014 Jan 1
• 9 citations
  Trichodysplasia spinulosa in an adolescent with cystic fibrosis and lung transplantation.
  David R. Berk, Dongsi Lu, Susan J. Bayliss> ;International Journal of Dermatology. 2013 Dec 1
• 2 citations
  Focal preauricular dermal dysplasia in a newborn.
  Carrie C. Coughlin, Scott W. Dunbar, Susan J. Bayliss, David R. Berk> ;Pediatric Dermatology. 2013 Nov 1
• 4 citations
  Photopneumatic therapy for the treatment of keratosis pilaris.
  Heather M. Ciliberto, Arta Farshidi, David R. Berk, Susan J. Bayliss> ;Journal of Drugs in Dermatology. 2013 Jul 1
• 4 citations
  Temporal trends in mucocutaneous findings among human immunodeficiency virus 1-infected children in a population-based cohort.
  Amy S. Sturt, Andrew Anglemyer, David R. Berk, Yvonne A. Maldonado> ;Pediatric Dermatology. 2013 Jul 1
• 3 citations
  Heel‐Line Hyperpigmentation: A Variant of Sock‐Line Hyperpigmentation After the Use of Heel‐Length Socks
  Heather Ciliberto, David Berk, Pankaj Salphale, Susan Bayliss> ;Pediatric Dermatology. 2013 Jul 1
• 5 citations
  Pili annulati: a report of 2 American families.
  David R. Berk, Susan J. Bayliss, Kathrin A. Giehl> ;Cutis. 2013 May 1
• 6 citations
  Scleral hemangioma: case report and response to propranolol.
  David R. Berk, Susan M. Culican, Susan J. Bayliss> ;Pediatric Dermatology. 2013 May 1
• 14 citations
  The course of lichen sclerosus diagnosed prior to puberty.
  Mariel A. Focseneanu, Monique Gupta, Kathryn C. Squires, Susan J. Bayliss, David R. Berk, Diane F. Merritt> ;Journal of Pediatric and Adolescent Gynecology. 2013 Jun 1
• Join now to see all